AOD-9604 is a synthetic, 16-amino acid peptide derived from the C-terminal fragment of human growth hormone (hGH), specifically matching amino acids 177–191 with an added tyrosine residue. It was developed to mimic the lipolytic (fat-cleaving) properties of naturally occurring hGH by stimulating fat breakdown and inhibiting the transformation of non-fatty foods into body fat. Notably, because AOD-9604 is a fragment and acts independently of the standard hGH receptor pathway, research suggests it does not induce the systemic anabolic effects or insulin resistance typically associated with intact hGH therapy Not FDA-Approved: Compounded medications are customized for individual patients and are not FDA-approved finished drug products. Patient-Specific: Dispensed only pursuant to a valid, patient-specific prescription from a licensed healthcare provider based on a documented clinical need. No Approved Indication: This peptide is not approved by the FDA for the treatment of obesity or any other specific medical condition.
